Girl’s undisclosed death in gene-editing trial raises red flags in booming Chinese industry
Beijing — A top Chinese medical university is investigating the death of a young girl in an experimental gene-editing trial conducted by a leading expert at its affiliated hospital that has raised serious concerns about ethics in China’s booming biomedical industry.
Under a treatment plan he developed for the family, the girl would be the first person in the world to receive a gene-editing therapy directed at the brain, according to Science.
The hospital’s ethics board concluded the girl’s death was “definitely related” to the treatment, but penalties were minor and the outcome was never made public by the doctors or their institutions, even as results from related research were published in the prestigious science journal Nature, the Science report revealed.
This is a summary of the original articles listed below. Always read the source articles for the full context. GhanaSummary does not create or modify the news — we summarise and link to original publishers.
